Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

European Innovation Council · Running

Prometeus Preterm Brain-Oxygenation and Metabolic EU-Sensing: Feed the Brain

Coordinator
Universita Degli Studi Di Padova, Italy
Runs
1 February 2023 to 31 January 2028
Status
Running
EU funding
€3.6m
Total cost
€3.6m
Partners
11 organisations in 6 countries
Type
European Innovation Council
Grant agreement
101099093

What the project is doing

In the project's own words, from its summary on CORDIS.

Prometeus introduces a new-paradigm for personalized nutrition of prematurely born neonates in neonatal intensive care unit (NICU), by developing a groundbreaking technology for real-time adjustment of glucose and nutrients intakes to target neonatal brain needs. The brain of a baby born prematurely is highly susceptible to early neonatal injuries that, in turn, increase the risk for neurodevelopmental disability. Provision of adequate nutrients and oxygen is essential for proper brain development and growth.

However, current nutritional strategies are unfit to target real-time brain necessities, and are driven by pre-specified (non personalised) nutritional charts, in the absence of contemporary cot-side monitoring of both brain “health” and metabolic supplies. As a consequence, sudden changes of brain fuel-requirements cannot be promptly addressed by real-time adjustment of glucose and nutrients provision. Prometeus will develop a metabolic model of the interaction between the three key brain fuels [glucose, lactate and beta-hydroxybutyrate (BHB)] and their effect on regional cerebral blood flow (CBF), oxygen saturation (StO2) and metabolism (CMRO2).

The model will serve to individualize brain nutrition targeting “brain health” according to the inputs derived from two novel minimally invasive metabolic sensing systems: a wearable cap measuring regional CBF, StO2 and CMRO2 and a subcutaneous miniaturized metabolic sensor for glucose, lactate and BHB. The system will create a metabolic “womb” to feed the brain of preterm neonates. Prometeus will be paralleled by a parent-dedicated interface, exploiting a purposely developed family adjusted visual language, that will inform parents of preterm babies during their NICU admission and stay.

Prometeus will dramatically reduce the risk for prematurity-associated disability in Europe and worldwide, with a consequent incalculable ethical, social and economic impact.

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di PadovaPadovaItalyCoordinator
Fundacio Institut De Ciencies FotoniquesCastelldefelsSpainParticipant
Universitat De GironaGironaSpainParticipant
Institut National De La Sante Et De La Recherche MedicaleParisFranceThird party
Universite Grenoble AlpesGrenobleFranceParticipant
University College Cork - National University of Ireland, CorkCorkIrelandParticipant
Qulab Medical Ltd.HerzliyaIsraelParticipant
Dave SRLPorciaItalyParticipant
Pionirs SRLMilanoItalyParticipant
Politecnico Di MilanoMilanoItalyParticipant
University College LondonLondonUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI